Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Cyclin-dependent kinases as targets for cancer therapy.
Manish A. Shah
, Gary K. Schwartz
Research output
:
Contribution to journal
›
Review article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cyclin-dependent kinases as targets for cancer therapy.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cyclin-dependent Kinase
100%
Cancer Therapy
100%
Cytotoxic Agents
100%
Cell Cycle Perturbation
100%
Patients with Cancer
50%
Malignancy
50%
Patient Care
50%
Antitumor Activity
50%
Drug Resistance
50%
Clinical Investigation
50%
Emerging Alternatives
50%
Phase II Study
50%
Anticancer Therapy
50%
CDK Inhibitors
50%
Antitumor Agents
50%
Clinical Activity
50%
Human Malignancies
50%
Combination Studies
50%
Agent Evaluation
50%
Medicine and Dentistry
Cell Cycle
100%
Cancer Therapy
100%
Cyclin-Dependent Kinase
100%
Cancer
66%
Cytotoxic Agent
66%
Neoplasm
33%
Antineoplastic Activity
33%
Clinical Study
33%
Drug Resistance
33%
Cancer Treatment
33%
CDK Inhibitor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
100%
Cyclin Dependent Kinase
100%
Cytotoxic Agent
100%
Preclinical Study
50%
Drug Resistance
50%